Compare Chemcon Special. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -20.32% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 8.18% signifying low profitability per unit of shareholders funds
Positive results in Jun 26
With ROE of 5.8, it has a Very Expensive valuation with a 1.7 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 828 Cr (Micro Cap)
29.00
42
2.88%
-0.30
5.83%
1.71
Total Returns (Price + Dividend) 
Latest dividend: 6.500000000000001 per share ex-dividend date: May-27-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Chemcon Speciality Chemicals Ltd Upgraded to Hold on Technical and Financial Improvements
Chemcon Speciality Chemicals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial performance. Despite lingering concerns over valuation and long-term fundamentals, the company’s enhanced technical trend and positive quarterly results have prompted a reassessment of its outlook by analysts.
Read full news article
Chemcon Speciality Chemicals Ltd Sees Bullish Momentum Amid Technical Upgrades
Chemcon Speciality Chemicals Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from mildly bullish to bullish territory. Despite some mixed signals across weekly and monthly charts, the stock’s recent performance and technical parameters suggest a cautiously optimistic outlook for investors in the specialty chemicals sector.
Read full news article
Chemcon Speciality Chemicals Ltd Sees Mixed Technical Signals Amid Mildly Bullish Momentum
Chemcon Speciality Chemicals Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade to Sell, the stock’s price action and technical indicators reveal a cautiously optimistic outlook tempered by underlying weaknesses.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18-Sep-2026 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Shareholder Meeting / Postal Ballot-Outcome of AGM
17-Sep-2026 | Source : BSEProceedings of the 37th Annual General Meeting
Shareholder Meeting / Postal Ballot-Scrutinizers Report
17-Sep-2026 | Source : BSEScrutinizers Report on e-voting conducted for the 37th AGM
Corporate Actions 
No Upcoming Board Meetings
Chemcon Speciality Chemicals Ltd has declared 65% dividend, ex-date: 27 May 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 5 FIIs (0.25%)
Kamalkumar Rajendra Aggarwal (27.81%)
None
22.95%
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -11.84% vs 31.55% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 72.06% vs 25.15% in Mar 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 9.28% vs -36.50% in Sep 2024
Growth in half year ended Sep 2025 is 3.68% vs -1.27% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 7.90% vs -26.50% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -16.04% vs 25.91% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 15.71% vs -22.35% in Mar 2025
YoY Growth in year ended Mar 2026 is -3.48% vs 27.41% in Mar 2025






